查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529792

胜肽微阵列市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2024-2030 年

Peptide Microarray Market Size, Share & Trends Analysis Report By Type (Reagents, Services), Application (Disease Diagnostics, Protein Functional Analysis), By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

胜胜肽微阵列市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球胜胜肽微阵列市场规模将达到4.273亿美元，2024年至2030年复合年增长率为6.18%。

预计市场在预测期内将保持稳定成长。该技术包括临床分析和蛋白质体学领域的高通量技术。胜肽微阵列可以透过光谱、质谱和萤光成像进行分析。它在医学、药学、生物学等领域有着广泛的应用。它是一种先进的自动化技术，可以从实验中收集大量资料，用于寻找治疗方法、诊断疾病和开发诊断技术。

此方法用于识别新的药物标靶。细菌蛋白表面抗原的检测、抗体测定、免疫抗原性鑑定、表位作图、生物标记检验、血清分析、酵素表征、HLA 分析等是胜肽微阵列的一些应用。使用胜肽微阵列进行诊断测试开发被认为是行业成长的关键决定因素。根据 2021 年 3 月发表的一项研究，胜肽微阵列可以为开发基于 COVID-19 的诊断测试提供抗原的重要见解。调查团队使用胜肽微阵列来筛检样本中的病毒抗体。因此，基于胜肽微阵列的测试方法的发展有望促进该行业的成长。

例如，JPT Peptide Technologies 将用于 COVID-19 和感染疾病的胜胜肽微阵列商业化，零售价为 324 美元。该技术可用于免疫检测和监测、生物标记发现以及蛋白质相互作用检验。主要企业正致力于策略性努力，在全球范围内建立强大的分销网络。例如，PEPperPRINT GmbH、4A Biotech Co. Ltd.、Filgen, Inc.、Tokyo Mirai Style、AbClon Inc.、Tokyo Mirai Style Taiwan、Sciencewerke Co.。这项策略使公司能够避免监管和客户获取成本。

胜肽微阵列市场报告亮点

  • 由于许多製药和生物技术公司建立了内部研究站进行抗体研究，设备类型细分市场相对比服务细分市场更加成熟，并且在 2023 年占据最大份额。
  • 由于新兴市场感染疾病的高流行，疾病诊断应用领域在 2023 年占据了最大的销售份额。例如，PEPperPRINT GmbH 提供针对超过 32 种感染疾病的胜肽微阵列。
  • 製药和生物技术公司的最终用户部分在 2023 年占据了最大的收益占有率，因为它广泛用于抗体表征和蛋白质相互作用检验。
  • 由于该地区医疗保健设施的建立以及研发领域投资的增加，北美地区在 2023 年的总收益中所占份额最大。
  • 医疗保健专业人员和患者对慢性病早期发现和治疗的认识不断提高，也提高了诊断能力并推动了该地区的成长。
  • 此外，慢性病和感染疾病等疾病的日益普及正在促使企业进入该区域市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章胜肽微阵列市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 胜肽微阵列市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章胜肽微阵列市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球胜胜肽微阵列市场：按类型分類的变异分析
  • 全球胜胜肽微阵列市场：2018-2030 年按类型分類的规模和趋势分析
  • 装置
  • 试剂
  • 服务

第五章胜肽微阵列市场：按应用估算和趋势分析

  • 细分仪表板
  • 全球胜胜肽微阵列市场：依应用进行变异分析
  • 全球胜胜肽微阵列市场：规模和趋势分析（按应用），2018-2030
  • 疾病诊断
  • 蛋白质功能分析
  • 抗体表征
  • 药物发现

第六章胜肽微阵列市场：按最终用途分类的估计和趋势分析

  • 细分仪表板
  • 全球胜胜肽微阵列市场：最终用途的变异分析
  • 全球胜胜肽微阵列市场：规模和趋势分析（按最终用途），2018-2030 年
  • 製药和生物技术公司
  • 医院/诊所
  • 诊断中心
  • 其他的

第七章胜肽微阵列市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域应用市场仪表板
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 2018年至2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018年至2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018年至2030年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • PEPperPRINT GmbH
    • RayBiotech, Inc.
    • Creative Biolabs.
    • Aurora Biomed Inc.
    • Kinexus Bioinformatics Corporation
    • Bio-Synthesis Inc.
    • Microarrays Inc.
    • Arryait Corporation（ARYC）.
    • JPT Peptide Technologies
    • Merck KGaA
    • Innopsys
    • Nimble Therapeutics, Inc.
Product Code: GVR-4-68040-028-1

Peptide Microarray Market Growth & Trends:

The global peptide microarray market size is expected to reach USD 427.3 million by 2030, registering a CAGR of 6.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate during the forecast period. The technique includes high throughput technologies in the area of clinical assays and proteomics. Peptide microarray can be analyzed through spectroscopy, mass spectrometry, and imaging via fluorescence. It has considerable applications in the field of medicine, pharmacology, and biology. It is one of the automated advanced technologies to collect a large volume of data from an experiment employed for therapeutic discoveries, disease diagnosis, and diagnostic technique development.

The method is employed to identify new drug targets. To detect the antigen present on the protein surface of bacteria, determination of Abs, immunogenic Identification, mapping of the epitope, biomarker validation, serum profiling, enzyme characterization, and HLA profiling are some of the applications of the peptide microarray. The use of peptide microarray for developing diagnostic tests is considered to be an important determinant of industry growth. According to research published in March 2021, peptide microarray can offer significant insights into the antigens for developing the COVID-19-based diagnostic test. Researchers used peptide microarrays to screen the samples for antibodies against the virus. Hence, the development of peptide microarray-based tests is expected to boost industry growth.

For instance, JPT Peptide Technologies commercializes peptide microarray for COVID-19 and infectious conditions at the retail price of USD 324. The technology can be used for immune detection and monitoring, biomarker discovery, and protein interaction validation. Key players are focusing on strategic initiatives to establish a strong distribution network across the globe. For instance, PEPperPRINT GmbH created its presence in the Asia Pacific regional market through distributors such as 4A Biotech Co., Ltd., Filgen, Inc., Tokyo Future Style, Inc., AbClon Inc., Tokyo Future Style Taiwan, Inc., Sciencewerke Co., Ltd., and TrendBio. The company adopted an indirect distribution strategy in the region. The strategy assisted the company to avoid the costs of regulatory compliance and customer acquisitions.

Peptide Microarray Market Report Highlights:

  • The instruments type segment is relatively more mature than the services segment and held the largest share in 2023 due to the high number of pharma & biotech companies establishing in-house research stations for antibody-based research
  • The disease diagnostics application segment captured the largest revenue share in 2023 owing to the high incidence of infectious diseases in emerging markets. For instance, PEPperPRINT GmbH offers peptide microarray for over 32 infectious conditions
  • The pharmaceutical & biotechnology companies end-user segment held the maximum revenue share in 2023 due to the wide use of antibody characterization and validation of protein interactions
  • North America accounted for the largest share of the overall revenue in 2023 due to the well-established healthcare facilities in this region along with increased investment in the R&D sector
  • The rising awareness among healthcare professionals and patients about the early detection and treatment of chronic diseases also speeds up diagnostic capabilities and boosts the region's growth
  • Moreover, the increasing incidence of diseases, such as chronic and infectious diseases, is encouraging companies to enter the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Peptide Microarrays Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing burden of chronic diseases
      • 3.2.1.2. Technological advancements in diagnostic testing
      • 3.2.1.3. Rising adoption of peptide microarrays
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Reimbursement issues
  • 3.3. Peptide Microarrays Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Peptide Microarrays Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Peptide Microarrays Market Type Movement Analysis
  • 4.3. Global Peptide Microarrays Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Peptide Microarrays Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Peptide Microarrays Market Application Movement Analysis
  • 5.3. Global Peptide Microarrays Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Disease Diagnosis
    • 5.4.1. Disease diagnosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Protein Functional Analysis
    • 5.5.1. Protein functional analysis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Antibody Characterization
    • 5.6.1. Antibody characterization market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Drug Discovery
    • 5.7.1. Drug discovery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Peptide Microarrays Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Peptide Microarrays Market End Use Movement Analysis
  • 6.3. Global Peptide Microarrays Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Hospitals & Clinics
    • 6.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Peptide Microarrays Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. PEPperPRINT GmbH
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. RayBiotech, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Creative Biolabs.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Aurora Biomed Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Kinexus Bioinformatics Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Bio-Synthesis Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Microarrays Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Arryait Corporation (ARYC).
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. JPT Peptide Technologies
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
    • 8.4.10. Merck KGaA
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Innopsys
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Nimble Therapeutics, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global peptide microarray market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 North America peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 26 UK peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 France peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 30 France peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 31 France peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 China peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 52 China peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 53 China peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 India peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 58 India peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 59 India peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Argentina peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 MEA peptide microarray market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Africa peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 89 UAE peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE peptide microarray market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait peptide microarray market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait peptide microarray market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait peptide microarray market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Peptide microarray market: Market outlook
  • Fig. 5 Peptide microarray market: Segment outlook
  • Fig. 6 Peptide microarray market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Peptide microarray market driver impact
  • Fig. 9 Peptide microarray market restraint impact
  • Fig. 10 Peptide microarray market: Type outlook and key takeaways
  • Fig. 11 Peptide microarray market: Type movement analysis
  • Fig. 12 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Reagents microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Services microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Peptide microarray market: Application outlook and key takeaways
  • Fig. 16 Peptide microarray market: Application movement analysis
  • Fig. 17 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Protein functional analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Antibody characterization market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Peptide microarray market: End Use outlook and key takeaways
  • Fig. 22 Peptide microarray market: End Use movement analysis
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Global peptide microarray market: Regional outlook and key takeaways
  • Fig. 28 Global peptide microarray market: Regional movement analysis
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)